³X«È Åwªï±z!   ·|­ûµn¤J


 ¦^¥D­¶  ¡÷    ªc§¿*¯«¸g¥~/¤º¬ì  ¡÷  ¥»½g¥DÃD¡G¸£½F¤Î¯á´Õ½F¤§³B²z



 
¡i¤W¤@½g¡j[ µÌ¯«¸g¨ü·l ] ¡i¤U¤@½g¡j[ §¤°©¯«¸gµh-´Õ¶¡½L¬ð¥X ]

    [¤À¨É]    ¸£½F¤Î¯á´Õ½F¤§³B²z

    wendy   µoªí©ó 2007/7/1 9:32:36



¥Ò¡B ¸£½F 1.¤ÀÃþ(WHO, 1990) A.¯«¸g¤W¥Ö©Ê²Õ´¸~½F a.¬Pª¬²Ó­M½F I.Astrocytoma, (12.6%) II.Malignant astrocytoma III.GBM (glioblastoma multiforme) (6.3%) IV.Pilocytic astrocytoma V.Pleomorphic xanthoastrocytoma b.Oligodendroglioma (1.6%) c.Ependymoma (1.6%) d.mixed glioma e.Choroid plexus tumors¡G¦pchoroid plexns papiloma (0.5%) f.°_·½¤£©ú¤§¤W¥Ö©Ê¸~½F¦pastroblastoma g.¯«¸g²Ó­M©Ê¤Î²V¦X¯«¸g½¦²Ó­M©Ê½F¡G ¦pgangliocytoma, ganglioglioma h.ªQªGÅé¸~½F¡G¦ppineocytoma, pineoblastoma B.embryonal tumors¡G a.medulloepithelioma b.neuroblastoma c.epencymoblastoma d.retinoblastoma e.PNET (primitive neuroectodermal tumors)¦pMedulloblastoma (1.5%) C.¸£¯áÅ诫¸g¸~½F(6.6%) a.schwannoma(©Îneurilemoma, neurinoma) b.neurofibroma D.meningeal tumor a.meningioma (23.3%) b.¸£½¤²Ó­M¥H¥~¥Ñ¤¤­F¼h¨ÓªÌ I.¨}©Ê¡Gchondroma, lipoma, fibroma II.´c©Ê¡Gchondrosarcoma, Rhabdomyosarcoma c.­ìµo©Ê¶Â¦â¯À²Ó­M½F d.°_·½¤£©úªÌ¡Ghemangioblastoma, hemangioericytoma E.³y¦å²Õ´ ¦pmalignant lymphoma¡Bplasmacytoma F.germ cell tumors ¦pgerminoma, embryonal carcinoma, yalksac tumor, choriocarcinoma, teratoma G.cystic and tumor like lesions ¦pRathke s cleft cyst, epidermoid cyst, Dermoid cyst,²Ä¤T¸£«Çcolloid cyst H.¸£««Åé¸~½F¡G¦ppituitary adenoma (20.6%) pituitary carcinoma I.local extension from regional tumors a.craniopharyngioma(¤Àadamantinomatous, squamous, papillary¤T«¬) b.paraganglioma c.Chordoma d.chondroma J.metastatic tumors (14.1%)¡¯¬A©·¤º¤§¦Ê¤À¤ñ¬°1997¦~°ªÂ大²Î­p 2.¸£½F¤§¯SÂI A.glioima³Ì±`¨£¡A¨ä¥L¨Ì¦¸¬°meningioma, pituitary adenoma, metastatic tumor B.©Ê§O¡G¨k:¤k¬°55:45¡A¦ý¦bschwannoma©Mmeningioma¥H¤k©Ê¬°¦h C.¦¨¤H©M¤p«Ä¦nµo¤§¸~½F¤£¦P¡G¦¨¤H¥H¤Ñ¹õ¤W°Ï¬°¦h¡A¦Ó¤p«Ä¥H¤Ñ¹õ¤U¬°¦h(¤G·³¥H¤U¤S¥H¤Ñ¹õ¤W°Ï¸û¦h) ¨àµ£±`¨£¤§¸£½F¬°¡Gcerebellar astrocytoma, medulloblastoma (PNET), ependymoma, brain stem glioma, craniopharyngioma, optic glioma ¦¨¦~¤H¤¤¦~¡B§§¦~¡Gglioma, pituitary adenoma, schwanoma, meningioma ¦Ñ¦~¤H¡Gmetastatic tumor, GBM





   µoªí¥DÃD ¦^ÂÐ¥DÃD

    wendy  ¦^ÂЩó  2007/7/1 9:32:55



3.¯gª¬¡G A.¸£³¡¸~½F¤j­P¥i¤À¤p¸£¤Ñ¹õ¤W©M¤Ñ¹õ¤U¸~½F B.¤j¸£¸~½F¦h¬°ªø´ÁÀYµh¡B§½³¡¯«¸g¯Ê·l¦p¤â¸}³Â¤ìµL¤O¡Bµø³¥ÁY¤p¡BÅöíw¡B¤º¤Àªc²§±`¡B¯«´¼¤H®æ§ïÅÜ¡C C.«á¸£ºÛ¸~½F¥D­n¬°º¥¶i©ÊÀYµh¡B¹Ã¦R¡BÂß·F©ÎªÏÅ餣¨ó½Õ¡B¨B¼i¤£Ã­¡B·w¯t¡B½Æµø¡B¸£¯«¸g¯Ê·lµ¥¡C D.Á{§É¯gª¬¥i¤À¬°¥|Ãþ a.IICP¡GÀYµh¡B¹Ã¦R¡Bpapilledema, diplopia, Abducent palsy (false localizing sign)·NÃÑ»Ùê¡A¦åÀ£¤W¤É¡Abradycardia,¬Æ¦Ücoma b.Seizure¡G¥Holigodendroglioma³Ì®e©öµo¥Íseizure (92%)¨ä¦¸¬O§C´c©Ê«×¤§astrocytoma (70%),¦A¦¸¬°meningioma(67%) c.§½³¡¯«¸g¥\¯à»Ùê¡A¨Ì«I¥Ç¤§°Ï°ì¤£¦P¡A¦³¤£¦P¤§¯gª¬ d.¤º¤Àªc¥\¯à¥¢½Õ¡G¼vÅT¨ìpituitary, hypothalamus,¤Îpineal gland·|¦³¤º¤Àªc¥¢½Õ 4.¶EÂ_ A.¸Ô²Óªº¯f¥v¤Î¯«¸g¾ÇÀˬd B.C-T Scan©ÎMRI¥i¨£²M·¡Åã¥Ü¸~½F¤§¸Ñ­å¦ì¸m¡A¸£¦åºÞÄá¼v(¤@¯ë¤£»Ý­nªº)¡A¥i¨£¸~½F»P¥¿±`¤§Ãö«Y¡B¹ï¥¿±`¦åºÞ³y¦¨¤§¼vÅT¡B¨ä¥»¨­¦åºÞ¤§¦h¹èµ¥¡C 5.ªvÀø A.¨C¤G¤p®É°O¿ý¥Í©Rªí¼x¡BGCS¡BÄá¤J±Æ¥X¶q¡C B.¨Ì·NÃѱ¡ªp¡A¨M©wÄá­¹¤è¦¡©M¶q¡C C.ÀR¯ß¿é²Gµ¹¤©0.33% D/S¡A¸T­¹¯f±w¨C¤Ñµ¹¤©35ml/kg¡A¶i­¹¯f±wºû«ùºZ³q§Y¥i¡C D.dexamethasone (decadron) 4-8 mg q6h¡C E.­Y¤ô¸£µo¥Í¡A¶·§@V-P shunt¡CGlycerol¹ï©ó¸£½F²£¥Í¤§Æ`¤ºÀ£¼W°ª®ÄªG¸û®t¡C F.Prevent stress ulcer: Zantac 50mg q6h¡C G.¤â³NºK°£¸~½F¡CCraniotomy with removal of tumor¡C H.·íÁ{§É¤W©Î¹q¸£Â_¼h¤W¡AÃhºÃ¦³Âಾ©Ê¸£½F¤§²{¶H¡A¶·§@¥þ¨­©Ê¤§Àˬd¡A¥H°»°¼­ìµo©Ê¯f¨_¡CIVPÀˬd¬O§_¦³µÇÀù¡AGI Series X¥ú©Î¤ºµøÃèÀˬd¬O§_¦³GI tract¤§Àù¯g¡C¬dGallium Scan¬O§_¦³²O¤ÚÀù¡A¶W­µªi¸¡³¡Àˬd¬O§_¦³¨xÀù¡B¯ØÅ¦Àù¡A¹ï©ó°ü¤k±wªÌ¶·Àˬd¨Å©Ð¤Î·|¶E°ü²£¬ìÀˬd¡A°ü¬ì¤§Àù¯g¡C¦P®É¥Í¤ÆÀˬdAFP, CEA, HCG¤§Tumor marker¡C­Y¯à§ä¨ì­ìµo©Ê¯f¨_¡AÂಾ©Ê¸£½F¤@¯ë¬O¤£¦A»Ý­n¤â³NªvÀøªº¡C ¤A¡B ¯á´Õ½F¡G 1.¯á´Õ½F¤j¬ù¦û©Ò¦³¸~½Fªº1%¡A¦û¤¤¼Ï¸~½Fªº5-25% 2.Á{§É¯gª¬¡G A.³q±`¬O½wºCº¥¶iªº B.¯áÅ褺¸~½F·|²£¥Ídissociated sensory disturbance,¦¹®Éµh·Åı»Ùê¦ý¬OIJ¡B¦ì¡B®¶°Êı¤´¥¿±`¡A³o¬O¦]³q¹L¤¤¤ß³¡¦ìªºspino-thalamic tract¤ñpostreior column¥ý¨ü¨ì«I¥Ç¡C³Ì«á·|¥X²{long tract sign,¦p¹B°ÊµL¤O¡B¥¢¸Tµ¥¡CÁ{§É¤W·|³y¦¨¤U¦æ©Ê¹B°Ê©Î·Pı¥\¯à´î®z¡A³o¬O¦]¬°long tract§elamination±Æ¦C¡A¤ä°tÀV¯Ý³¡¤§tract¦ì©ó¯áÅ褺°¼¡A¤ä°t¸yçY³¡ªÌ¦b¥~°¼¡C©Ò¥H¦³¥i¯à¶ÈçYÅ賡¤§tract¤£¨ü«I¥Ç¡A³±³¡·Pı¥¿±`ºÙ§@sacral sparing¡C C.¯áÅè¥~¸~½FÀ£­¢¤@°¼¥i¤Þ°_Brown-Sequard syndrome,¥X²{¦P°¼À@Åé®|¸ô¯gª¬¡F¦P°¼©T¦³·Pı®ø¥¢¤Î¹ï°¼µh·Pı®ø¥¢¡A¥Ñ©ó¤ä°tçY¸y³¡¤§tract¦ì©ó¥~°¼¡A©Ò¥H·|¥ý³Q¯áÅè¥~¸~½FÀ£­¢¨ì¡A¬G³y¦¨¤W¦æ©Ê¤§¹B°Ê©Î·Pı¥\¯à´î®z¡C 3.´¶³q¤§X¥ú¯á´ÕÄá¼v¬O¥²­nªº¡A¥HÀˬd¬O§_Âಾ©Ê°©ÀY¯f¨_¡C¯á´Õ¤§MRIÄá¼v¥i¥H«Ü§Ö³t¦a°»´ú¯f¨_¤§¦ì¸m¡C¥i°Ï§O¬O¡G Extradural tumor (ET) (55%) Intradural extramedullary tumors (IDEMT) (40%)©Î Intramedullary tumors (IMT) (5%) 4.¯á´Õ½F¤§ªvÀø¤´¥H¤â³N¬°¥D¡CÃhºÃ¯á´Õ½F²£¥Í¤§«æ©Ê¤UªÏ©Î¥|ªÏÅõºÈ¯f¤H¡A¶·ºò«æ¤â³N¤Á°£¸~½F¡C 5.¹ïT-spine¤§¯á´Õ½F¡A¤â³N«e¶·¥Î°j¯¾°w©Î°wÀY¡A©T©w©ó¯f¨_ªþªñ¡A·ÓX¥ú¡A§@¬°¤â³N«e©w¦ì¡A¥H¤è«K©ó¤â³N¤¤§ä¨ì¯f¨_¡C 6.ÃhºÃ¦³Âಾ©Ê¯á´Õ½F¤§¥i¯à¡A°»¬d­ìµo©Ê¯f¨_¤§¤èªk¡A¦pÂಾ©Ê¸£½F©Ò­z¡C 7.±`¨£¤§¯á´Õ½F¡G A.Extradural tumors¦nµo©ó¯Ý´Õ¦h¬°Metastatic tumor¦pLymphoma, lung, breast, prostate ca. B.Intradural extramedullary tumors¬°Meningioma, Neurofibroma, (Neurilemoma). C.Intramedullary tumors¬°astrocytomas, ependymoma.¨äµo¥Í²v¨Ì¦¸¬°Neurofibroma and Neurilemoma, meningioma, metastatic tumor, astrocytoma, ependymoma.





   µoªí¥DÃD ¦^ÂÐ¥DÃD

    wendy  ¦^ÂЩó  2007/7/1 9:37:52



¸£½FªvÀø ¸£½F ¸£¤U««Å鸢½F ´c©Ê¸£½F·sÀøªk ¸£¸~½F¤À¨}©Ê¸~½F¤Î´c©Ê¸~½F¡A­Y¬OÄÝ©ó¨}©Ê¸~½F¡A«h¤£·|ÂX´²¦Ü¨­Åé¨ä¥L³¡¦ì¡CµM¦Ó¡A©Ò¦³¸£¸~½F³£¥iª½±µ¼vÅT¸£¯«¸g¤Î¼W¥[Æ`°©¤ºªºÀ£¤O¡C ªvÀø ¸£¸~½F¤@¯ë³£¥i¥H¬I¥~¬ì¤â³N¤Á°£¡C©ñ®gÀøªk©M¤Æ¾ÇªvÀø¥i§@¤@¨Ç¸£¸~½F¦b¤â³N¤Á°£«áªº»²§UªvÀø¡C ªvÀø ¸£½FªºªvÀø¡A¥H¥~¬ì¤â³N¤Á°£¬°¥D¡F¥²­n®É¥H©ñ®g½uªvÀø©Î¤Æ¾ÇªvÀø¡A¥[±j©Î»²§U¤§¡C¤â³NªvÀø¥H¯à¥þ³¡¤Á°£¬°²z·Q¡C¦³¨Ç¸£½Fªø¦b·¥­«­n©ÎÀI­n³¡¦ì¡]¦p¸£·F³¡¦ì¡^©Î¥]³ò·¥­«­n¤§¦åºÞ¯«¸g¡A¦ÓµLªk©Î¤£©y§¹¥þºK°£¡A¦³¨Ç¸£½F§e¼ç¥ñ©Êº¯³z¥Íªø¡A¨Æ¹ê¤WµLªk¤Á°£°®²b¡A³o®É´N­n¥H©ñ®g½u¹qÀø¨ÓÀ°§U ©Î°t¦X¤Æ¾ÇÃĪ«ªºªvÀø¡A±©¦Ü¥Ø«e¡A¨äÀø®Ä¦³­­¡C ¦³¨Ç¸£½F¡Aªø¦b¸û²`³B©Îªþªñ­«­n¦åºÞ¯«¸g«Ü¦h¡A«h»Ý°t¦X¤â³NÅã·LÃè¤Îºë²Ó¤â³N¤u¨ã¡A¦³®ÉÁÙ­n¨Ï¥Î¹p®g©Î¶W­µªi§l¤Þ¾¹¡A¥H´î¤Ö¹ï¾Fªñ²Õ´ªº·l¶Ë¡B´î¤Ö¥X¦å¡B­°§C¤â³N¨Öµo¯g¡AÀò±o§ó²z·Qªº¤â³N¦¨ÁZ¡C ¤×¨ä¹ï¸û°íµw©Î¦h¦åºÞ©Êªº¸£½F¡A°t¦X¹p®g¤â³N¡A§ó¯à«P¶i¥~¬ì¤â³NªºÀø®Ä¡C¹ï©ó¤p©ó¥|¤½¤Àªº¸£½F¡A¥i¦Ò¼{¨Ï¥Î X¥ú¤M©Î¥[º¿¤M·Ó®gªvÀø¡C¨ä­ì²z¤D¶°¤¤©ñ®g½u·Ó®g¸£½F¡A¨Ï¸£½FÅܩʦº¤`¡C¥Ø«e¤wÃÒ¹ê¹ï¬Y¨Ç¸£½F½T¦³Àø®Ä¡A¦pÂಾ©Ê¸£½F¡B¸£¤U««Åé½F¡BÅ¥¯«¸g½Fµ¥¡C ¹w«á ¸£½FªvÀøªº¹w«á»P¸~½FªººØÃþ¡B¤À¤Æ¡B¦ì¸m¡B«I¥Ç½d³ò¤ÎªvÀø¤èªk¦³Ãö¡C¨Ò¦p²Ä¤G¯Å¬Pª¬²Ó­M½F¤j¦h¥iªv¡¡C¤p¨à±`¨£ªºÅè¥À²Ó­M½F­Y¥H¤â³N¤Î©ñ®g½u¦X¨ÖªvÀø¡A¤­¦~¥Í¦s²v¥i¹F50¢H¥H¤W¡C ¦p¤â³N¤Î©ñ®gªvÀø¤èªk¦b§Þ³N¤W§ó¨D§ïµ½¡A«h¸£½Fªºªv¡²v±N¥i¤j¬°´£°ª¡C





   µoªí¥DÃD ¦^ÂÐ¥DÃD

¦@  1  ­¶    ¥Ø«e  1      «e©¹¡G  ¿é¤J¼Æ¦r«öEnter

¤ý®v¤÷±M·~Àð¾À¤Á¤ÕÆp¤Õ¤Þ¤Õ¤uµ{ªA°È
¥x¥_Æp¤Õ¤Á³Î ¤T­«Æp¤Õ¤Á³Î
ªO¾ôÆp¤Õ¤Á³Î ·s²øÆp¤Õ¤Á³Î
Àð¾ÀÆp¤Õ¤Á³Î,Àð­±¤Þ¤ÕÆp¤Õ,¦aªOÆp¤Õ¤Á³Î

[±ÀÂ˵û»ù¦n©±] - 4C§Ö­×³sÂêªù¥« ±M·~ºû­×¶R½æ-µ§¹q+¤â¾÷+¹q¸£+Iphone+Ipad
·s¥_¦Á¤î©± (02) 7751-9182
·s¥_¥«¦Á¤î°ÏºÖ¼w¤@¸ô86«Ñ22¸¹
·s¥_ªO¾ô©± (02) 8257-3990
·s¥_¥«ªO¾ô°Ï¥|ºû¸ô137«Ñ10¸¹
®ç¶é¤j·Ë©± (03) 387-4353
®ç¶é¥«¤j·Ë°Ï¤¤µØ¸ô210¸¹
¥x¤¤¥«°Ï©± (04) 2201-1289
¥x¤¤¥«¤¤°Ï¥x¤¤¸ô140¸¹


   ¥xÆWÂåÀø½×¾Â ¦^³»ºÝ
¦Û¾AÀ³ºô­¶½d¥»


³sµ²Àu¨}¸ê°T¤J¤fºô ¥»¯¸¤J³ò½Ã¥Í¸p95¦~«×Àu¨}°·±d¸ê°Tºô¯¸ ¥xÆWÂåÀøºô © 2006 Taiwan Inc. All Rights Reserved.

*«ØÄ³IE5.0¥H¤W¤§ÂsÄý¾¹ ¸ÑªR1024*768 ¥H¹F³Ì¨ÎÂsÄý®ÄªG* ¥þ¯¸¨Ì¤º®e¤À¯Å³W©w³B²z